Sarah Warren

2007–2025 年に発表

62
論文数
18,198
被引用数
39
h 指数
61
i10 指数

被引用数

Sarah Warren の年別被引用数1971 年: 被引用 1 件1987 年: 被引用 1 件1993 年: 被引用 2 件2007 年: 被引用 2 件2008 年: 被引用 19 件2009 年: 被引用 27 件2010 年: 被引用 47 件2011 年: 被引用 113 件2012 年: 被引用 97 件2013 年: 被引用 107 件2014 年: 被引用 71 件2015 年: 被引用 84 件2016 年: 被引用 52 件2017 年: 被引用 68 件2018 年: 被引用 49 件2019 年: 被引用 297 件2020 年: 被引用 923 件2021 年: 被引用 1,459 件2022 年: 被引用 1,530 件2023 年: 被引用 1,103 件2024 年: 被引用 1,527 件2025 年: 被引用 804 件2026 年: 被引用 28 件1972〜1986 年は被引用が無いため表示していません1988〜1992 年は被引用が無いため表示していません1994〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,830 件、この内訳の 25.3%中国: 引用元論文 2,055 件、この内訳の 18.4%イギリス: 引用元論文 636 件、この内訳の 5.7%ドイツ: 引用元論文 549 件、この内訳の 4.9%フランス: 引用元論文 427 件、この内訳の 3.8%イタリア: 引用元論文 423 件、この内訳の 3.8%オーストラリア: 引用元論文 375 件、この内訳の 3.3%オランダ: 引用元論文 361 件、この内訳の 3.2%スイス: 引用元論文 298 件、この内訳の 2.7%日本: 引用元論文 294 件、この内訳の 2.6%カナダ: 引用元論文 281 件、この内訳の 2.5%スペイン: 引用元論文 244 件、この内訳の 2.2%
0%25.3%その他 21.6%

分野

  • Medicine50.6%
  • Biochemistry, Genetics and Molecular Biology29.3%
  • Immunology and Microbiology14.9%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.9%
  • Neuroscience0.8%
  • その他2.1%

トピック

  • Cancer Immunotherapy and Biomarkers12%
  • Immunotherapy and Immune Responses6.9%
  • Inflammasome and immune disorders4.1%
  • Immune Cell Function and Interaction4%
  • Immune cells in cancer3.7%
  • CAR-T cell therapy research3.6%
  • その他65.7%

共著者

全論文

検索で開く
  1. B cells and tertiary lymphoid structures promote immunotherapy response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 被引用: 2,745

  2. Tertiary lymphoid structures improve immunotherapy and survival in melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 被引用: 2,413

  3. Multiplex digital spatial profiling of proteins and RNA in fixed tissue

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2020 被引用: 1,077

  4. Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

    著者: , , , , , , , , , , , , , , , , , , , , , , - Immunity 2018 被引用: 937

  5. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine C. Linn, Ton N. Schumacher, Christian U. Blank, Marleen Kok - Nature Medicine 2019 被引用: 889

  6. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Malika Sud, Victoria M. Tran, Shamsudheen Karuthedath Vellarikkal, Yiping Wang, Liat Amir-Zilberstein, Deepak Atri, Joseph Beechem, Olga R. Brook, Jonathan Chen, Prajan Divakar, Phylicia Dorceus, J Engreitz, Adam L. Essene, Donna M. Fitzgerald, Robin Fropf, Steven Gazal, Joshua Gould, John Grzyb, Tyler Harvey, Jonathan L. Hecht, Tyler Hether, Judit Jané‐Valbuena, Michael Leney-Greene, Hui Ma, Cristin McCabe, Daniel E. McLoughlin, Eric Miller, Christoph Muus, Mari Niemi, Robert F. Padera, Liuliu Pan, Deepti Pant, Carmel Pe’er, Jenna Pfiffner-Borges, Christopher J. Pinto, Jacob Plaisted, Jason Reeves, Marty Ross, Melissa A. Rudy, Erroll H. Rueckert, Michelle Siciliano, Alexander Sturm, Ellen Todres, Avinash Waghray, Sarah Warren, Shuting Zhang, Daniel R. Zollinger, Lisa A. Cosimi, Rajat M. Gupta, Nir Hacohen, Hanina Hibshoosh, Winston Hide, Alkes L. Price, Jayaraj Rajagopal, Purushothama Rao Tata, Stefan Riedel, Gyöngyi Szabó, Timothy L. Tickle, Patrick T. Ellinor, Deborah T. Hung, Pardis C. Sabeti, Richard Novák, Robert Rogers, Donald E. Ingber, Z. Gordon Jiang, Dejan Juric, Mehrtash Babadi, Samouil L. Farhi, Benjamin Izar, James R. Stone ほか 9 名 - Nature 2021 被引用: 883

  7. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 被引用: 855

  8. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Durez, Maya H Buch, Hasan Rizvi, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Vasco C. Romão, João Eurico Fonseca, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar DasGupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Julio Ramírez, Raquel Celis, Robert J. Moots, Peter C. Taylor, C J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Gaye Hadfield, Costantino Pitzalis - Nature Medicine 2022 被引用: 279

  9. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria

    著者: , , , , , , , , - Nature Immunology 2010 被引用: 1,331

  10. Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , SuFey Ong, Sarah Warren, Tobias Pukrop, Philipp Beckhove, Sven Arke Lang, Tobias Bopp, Christian U. Blank, John L. Cleveland, Peter J. Oefner, Katja Dettmer, Mark Selby, Marina Kreutz - Cell Reports 2019 被引用: 298

  11. Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 209

  12. The spatial landscape of lung pathology during COVID-19 progression

    著者: , , , , , , , , , , , , , , , , , - Nature 2021 被引用: 402

  13. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

    著者: , , , , , , , , - Journal for ImmunoTherapy of Cancer 2018 被引用: 425

  14. TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

    著者: , , , , , , , , , , , , , , , , , , , , - Blood 2020 被引用: 188

  15. The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Translational Medicine 2019 被引用: 150

  16. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome

    著者: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 被引用: 794

  17. Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nagireddy Putluri, Donald E. Mager, Rudiyanto Gunawan, Martin A. Cheever, Sebastiano Battaglia, Junko Matsuzaki - Science Translational Medicine 2022 被引用: 67

  18. High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling

    著者: , , , , , , , , , - Clinical Cancer Research 2019 被引用: 172

  19. Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Yellin, Mary L. Disis, Martin A. Cheever, Steven P. Fling - Nature Cancer 2020 被引用: 126

  20. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nisha Singh, David P. J. Turner, Paul Turner, L L Walker, Rachel White, Jonathan S Nguyen-Van-Tam, Matthew D. Snape, Alasdair Munro, Jazz Bartholomew, Laura Presland, Sarah Horswill, Sarah Warren, Sophie Varkonyi-Clifford, Stephen Saich, Kirsty Adams, Marivic Ricamara, Nicola Turner, Nicole Y Yee Ting, Sarah Whittley, Tommy Rampling, Amisha Desai, Claire Brown, Ehsaan Qureshi, Karishma Gokani, Kush Naker, Johanna Kellett Wright, Rachel Williams, Tawassal Riaz, Florentina Penciu, Claudio Di Maso, Elizabeth Howe, Iason Vichos, Mujtaba Ghulam Farooq, Rabiullah Noristani, Xin L Yao, Neil J. Oldfield, Daniel Hammersley, Sue Belton, Simon Royal, Alberto San Francisco Ramos, Cecilia Hultin, Eva Galiza, Farah Shiham, Carla Solórzano, Hannah Sainsbury, Kelly Davies, Pauline Ambrose, Lisa Hitchins, Natalie Baker, Stephanie Leung, Ross Fothergill, Kerry Godwin, Karen R. Buttigieg, Imam H. Shaik, Phill Brown, Chanice Knight, Paminder Lall, Lauren Allen - The Lancet 2021 被引用: 545

  21. Gene expression markers of Tumor Infiltrating Leukocytes

    著者: , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2016 被引用: 850

  22. Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 44

  23. A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda E. Sanders, Jeffrey A. Sosman, Justin M. Balko - Nature Medicine 2019 被引用: 176

  24. Comprehensive analysis of cutaneous and uveal melanoma liver metastases

    著者: , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 被引用: 73